🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/04/2024 | 70,40 | 70,80 | 69,69 | 69,89 | -0,81% | 1,58% | 122.100 |
| 29/04/2024 | 70,99 | 71,96 | 69,63 | 70,46 | -0,16% | 3,28% | 197.700 |
| 26/04/2024 | 70,59 | 72,08 | 70,43 | 70,57 | +0,28% | 2,34% | 88.200 |
| 25/04/2024 | 70,24 | 71,17 | 69,63 | 70,37 | -0,89% | 2,19% | 106.700 |
| 24/04/2024 | 69,46 | 71,00 | 69,17 | 71,00 | +1,59% | 2,63% | 153.000 |
| 23/04/2024 | 68,50 | 71,16 | 68,50 | 69,89 | +1,98% | 3,88% | 140.700 |
| 22/04/2024 | 72,98 | 72,98 | 67,72 | 68,53 | -5,44% | 7,21% | 247.300 |
| 19/04/2024 | 71,93 | 72,95 | 71,16 | 72,47 | -0,07% | 2,49% | 137.200 |
| 18/04/2024 | 78,70 | 78,70 | 72,50 | 72,52 | -8,05% | 7,88% | 131.200 |
| 17/04/2024 | 79,92 | 80,53 | 78,30 | 78,87 | -1,31% | 2,79% | 179.800 |
| 16/04/2024 | 79,47 | 81,52 | 79,06 | 79,92 | +0,19% | 3,10% | 158.500 |
| 15/04/2024 | 80,81 | 80,96 | 79,09 | 79,77 | -1,95% | 2,31% | 175.600 |
| 12/04/2024 | 81,48 | 81,73 | 80,43 | 81,36 | -0,09% | 1,60% | 171.400 |
| 11/04/2024 | 81,42 | 81,56 | 80,58 | 81,43 | +0,80% | 1,20% | 147.200 |
| 10/04/2024 | 79,63 | 81,04 | 78,88 | 80,78 | -0,88% | 2,71% | 146.100 |
| 09/04/2024 | 79,46 | 81,64 | 78,89 | 81,50 | +2,39% | 3,46% | 142.100 |
| 08/04/2024 | 77,49 | 80,21 | 77,48 | 79,60 | +2,10% | 3,52% | 161.000 |
| 05/04/2024 | 77,45 | 78,35 | 76,02 | 77,96 | -0,03% | 3,01% | 165.700 |
| 04/04/2024 | 78,01 | 78,87 | 76,93 | 77,98 | +4,35% | 2,49% | 311.800 |
| 03/04/2024 | 72,60 | 74,88 | 72,51 | 74,73 | +2,08% | 3,26% | 102.000 |
| 02/04/2024 | 73,20 | 73,35 | 72,30 | 73,21 | -0,53% | 1,43% | 122.800 |
| 01/04/2024 | 73,35 | 73,62 | 71,22 | 73,60 | +0,68% | 3,27% | 181.100 |
| 28/03/2024 | 71,29 | 73,42 | 71,12 | 73,10 | +2,57% | 3,23% | 109.700 |
| 27/03/2024 | 69,26 | 71,85 | 68,80 | 71,27 | +3,83% | 4,40% | 191.700 |
| 26/03/2024 | 69,82 | 70,25 | 68,25 | 68,64 | -0,88% | 2,86% | 107.900 |
| 25/03/2024 | 71,38 | 71,68 | 68,98 | 69,25 | -2,46% | 3,78% | 107.100 |
| 22/03/2024 | 72,91 | 72,91 | 71,00 | 71,00 | -2,69% | 2,62% | 67.500 |
| 21/03/2024 | 73,74 | 73,88 | 72,42 | 72,96 | -0,21% | 1,98% | 91.200 |
| 20/03/2024 | 72,29 | 74,34 | 71,74 | 73,11 | +1,25% | 3,60% | 142.500 |
| 19/03/2024 | 71,74 | 73,03 | 71,72 | 72,21 | +0,10% | 1,83% | 101.900 |